Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Episode 3: ASCO GU 2024 Commentary: Kidney Cancer

Episode 3: ASCO GU 2024 Commentary: Kidney Cancer

FromThe View on GU | with Lalani and Wallis


Episode 3: ASCO GU 2024 Commentary: Kidney Cancer

FromThe View on GU | with Lalani and Wallis

ratings:
Length:
31 minutes
Released:
Feb 1, 2024
Format:
Podcast episode

Description

Filmed live at #GU24, episode 3 of The View on GU features a discussion on survival data with adjuvant therapy for patients with resected kidney cancer, as well as long-term followup for those with metastatic disease.

The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications into meaningful take home messages for practicing clinicians in the field of genitourinary (GU) cancers. Filmed live at the 2024 ASCO Genitourinary Cancers Symposium, Drs. Aly-Khan Lalani and Christopher Wallis discuss survival outcomes for adjuvant therapy, and exciting updated datasets in episode 3. Learn more about The View on GU: theviewongu.ca
Released:
Feb 1, 2024
Format:
Podcast episode

Titles in the series (8)

There is currently a lack of organic multi-disciplinary discussion on what is truly impactful to the field of genitourinary (GU) cancers. The View on GU with Lalani and Wallis is a podcast that will integrate key clinical data from major conferences and high impact publications into meaningful take home messages for practicing clinicians. Importantly, Lalani and Wallis will also discuss the impact of governmental approvals and funding considerations on the GU oncology treatment landscape and provide practical considerations on the management of patients on new-to-market therapies.